施樂輝 SNN 深 滬
交易中 04-01 10:50:57 美东时间
31.8799
+0.100
+0.31%
華盛通- 最 高31.95
- 今 開31.95
- 成交量 13.83万股
- 最 低 31.64
- 昨 收 31.78
- 總市值 135.33亿
- 52周最高 38.038
- 市盈率 靜 22.21
- 換手率 0.03%
- 52周最低 24.698
- 委 比 81.66%
- 總股本 4.24亿
- 歷史最高 47.416
- 量 比 1.27
- 振 幅 0.98%
- 歷史最低 8.426
- 每 手 1
- 風險率 3.42%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多UK Stocks-Factors to watch on March 26
UK Stocks-Factors to watch on March 26 March 26 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening lower on Thursday, with futures FFIc1 down 0.22%. * ANGLO AMERICAN: Anglo American AAL.L and Chile's Codelco have received a green light from the South American nation's antitrust regulator for
03-26 13:29
新浪财经ESG：施乐辉公司 MSCI（明晟）ESG评级调升至AA
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
03-24 10:30
Smith & Nephew plc publishes 2025 annual report
Smith & Nephew plc publishes 2025 annual report Smith+Nephew published its Annual Report 2025, reporting progress from its three-year 12-Point Plan transformation and outlining its new RISE strategy focused on reaching more patients, innovation, strategic investment and execution efficiency. The com
03-16 22:47
Smith+Nephew launches next-generation ALLEVYN™ COMPLETE CARE Foam Dressing - designed for high performance in wound management and pressure injury prevention
Smith+Nephew has launched the ALLEVYN COMPLETE CARE Foam Dressing, featuring a five-layer design with advanced technologies to minimize leakage, protect vulnerable skin, and prevent pressure injuries. Backed by clinical evidence, this innovative product absorbs up to 93% of mechanical energy, reducing pressure injury risk by over 65%. The dressing, available in multiple shapes and sizes, is initially launched in the US and will expand to internat...
03-10 14:30
施乐辉手持骨科机器人，亮相盛会
全球骨科巨头Smith&Nephew（施乐辉）宣布，将在即将举行的美国骨科医师学会年会（AAOS2026）上，重点展示手持外科机器人。 在直觉外科（达...
03-05 17:30
受美以对伊朗发动袭击影响 欧洲股市预计大幅下挫
美以周末对伊朗发动大规模袭击后，全球市场下挫，欧洲股市预计新交易周开盘大幅走低。 据IG数据显示：英国富时指数预计低开0.6%。德国DAX指数预计低开...
03-02 15:51
Smith+Nephew Inks Distribution Deal With RMR Ortho To Include A'TOMIC Nitinol Fixation System To Smith+Nephew Trauma, Foot & Ankle and Hand & Wrist Portfolio
Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces it has signed an exclusive US distribution agreement with RMR Ortho to add the A'TOMIC™ Nitinol Fixation System to the
02-24 23:31
Smith+Nephew signs exclusive US distribution agreement with RMR Ortho for patented technology that provides a unique dynamic compression nitinol fixation option (A'TOMIC™) to our surgeons
Smith+Nephew has signed an exclusive US distribution agreement with RMR Ortho to include the A'TOMIC™ Nitinol Fixation System in its Trauma, Foot & Ankle, and Hand & Wrist portfolio. The system, known for its compressive fixation technology, aims to enhance implant integrity and patient comfort. Scott Gunn, Vice President of Smith+Nephew, highlighted the collaboration as strengthening their fixation portfolio and enabling deeper surgeon engagemen...
02-24 15:28
Smith+Nephew signs distribution agreement with SI-BONE
Smith+Nephew and SI-BONE have partnered to distribute SI-BONE's iFuse TORQ portfolio, enhancing Smith+Nephew's offerings for pelvic fracture fixation and sacroiliac joint fusion. The collaboration aims to improve patient outcomes and expand access to innovative solutions. iFuse TORQ TNT has received FDA Breakthrough Device Designation and is eligible for Medicare reimbursement, providing a competitive advantage in the market.
02-23 21:30
